JP5650031B2 - Purification method for Horner-Wadsworth-Emmons reagent - Google Patents
Purification method for Horner-Wadsworth-Emmons reagent Download PDFInfo
- Publication number
- JP5650031B2 JP5650031B2 JP2011071941A JP2011071941A JP5650031B2 JP 5650031 B2 JP5650031 B2 JP 5650031B2 JP 2011071941 A JP2011071941 A JP 2011071941A JP 2011071941 A JP2011071941 A JP 2011071941A JP 5650031 B2 JP5650031 B2 JP 5650031B2
- Authority
- JP
- Japan
- Prior art keywords
- general formula
- wadsworth
- horner
- acid
- purifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Description
本発明は、ホーナー・ワズワース・エモンズ試薬(以下、HWE試薬ともいう)中に含まれているピロリン酸エステル類を選択的に除去するHWE試薬の精製方法に関するものである。 The present invention relates to a method for purifying an HWE reagent that selectively removes pyrophosphate esters contained in a Horner-Wadsworth-Emmons reagent (hereinafter also referred to as HWE reagent).
ホーナー・ワズワース・エモンズ反応(以下、HWE反応ともいう)は炭素−炭素二重結合を生成する反応として、医薬品や医薬中間体をはじめとした有機化合物の合成に広く用いられている。このHWE反応の基質として用いる一般式(I)で示されるHWE試薬は一般的にアルブゾフ反応を経て合成されている。
アルブゾフ反応においては亜リン酸トリエステル類とハロゲン化物を高温下で反応させる条件が一般的であり、その際に極微量の下記式(II)で示すピロリン酸エステル類が生成する可能性がある。
ピロリン酸エステル類はR部位の置換基によってもその強さは異なるがいずれも毒性を有しており、例えばRがエチル基のピロリン酸テトラエチル(TEPP)の場合はヒト男性経口LDLoが1700マイクログラム/キログラムと極めて高毒性であることから特定毒物に指定されており、目的化合物、特に医薬品類への混入は許されない。 Pyrophosphate esters have different toxicities depending on the substituent at the R site, but they are all toxic. For example, when R is tetraethyl pyrophosphate (TEPP) having an ethyl group, 1700 micrograms of human male oral LDLo / Kilogram is designated as a specific poison because of its extremely high toxicity, and it is not allowed to be mixed into the target compound, especially pharmaceuticals.
一般的に考えられる工業的に簡便でかつ経済的であり、不純物の除去効果も高い精製方法は蒸留であるが、ピロリン酸エステル類とHWE試薬の沸点は近接しており蒸留でのピロリン酸エステル類の除去は困難である。例えば、ピロリン酸エステルの沸点は前述のTEPPが125−130℃/5mmHgであるのに対して、上記一般式(I)においてXがCHCOOEt、YがCH3、R1がC2H5であるHWE試薬は157℃/5mmHg、同様にXがO、YがOEtであるHWE試薬は130℃/5mmHgである。一般的に沸点が近接している物質を蒸留によって分離する為には高段数の蒸留塔と大きな還流比が必要であり、設備費用と時間が掛かる。また、あまりにも沸点が近接している場合には分離自体が不可能である。 Distillation is a purification method that is generally considered to be industrially simple and economical, and has a high effect of removing impurities, but the boiling points of pyrophosphate esters and HWE reagents are close to each other, and pyrophosphate esters in distillation are used. Removal is difficult. For example, the boiling point of pyrophosphate ester is 125-130 ° C / 5 mmHg in the above-mentioned TEPP, whereas in the above general formula (I), X is CHCOOEt, Y is CH 3 , and R 1 is C 2 H 5 . The HWE reagent is 157 ° C./5 mmHg, and similarly, the HWE reagent in which X is O and Y is OEt is 130 ° C./5 mmHg. In general, in order to separate substances having boiling points close to each other by distillation, a high-stage distillation column and a large reflux ratio are required, which requires equipment costs and time. Further, when the boiling points are too close, separation itself is impossible.
別の方法としてピロリン酸エステル類の化学的性質を利用して除去する方法が考えられるが、このピロリン酸エステル類は加水分解することが報告されているものの(非特許文献1)、ピロリン酸エステル類が有機化合物中に極微量含まれている状態、特にHWE試薬のような同種の官能基を有した有機化合物中に極微量含まれている状態でピロリン酸エステル類のみを選択的かつ効果的に除去する方法は知られていない。 As another method, a removal method using the chemical properties of pyrophosphates can be considered. Although pyrophosphates have been reported to be hydrolyzed (Non-patent Document 1), pyrophosphates are used. Is only selective and effective in the state in which trace amounts are contained in organic compounds, especially in the state where trace amounts are contained in organic compounds having the same type of functional group as HWE reagent. There is no known removal method.
本発明者らは上記の課題を解決するために鋭意検討した結果、上記一般式(I)で示されるHWE試薬に含まれる上記一般式(II)で示されるピロリン酸エステル類を選択的かつ効果的に除去できることを見出し本発明に至った。すなわち、本発明はHWE試薬中に極微量含まれるピロリン酸エステル類を、HWE試薬の分解や変性を起こすことなく選択的かつ効果的に除去することが可能なHWE試薬の精製方法を提供することを目的とするものである。 As a result of intensive studies to solve the above problems, the present inventors have selectively and effectively selected pyrophosphate esters represented by the general formula (II) contained in the HWE reagent represented by the general formula (I). The present invention has been found to be able to be removed. That is, the present invention provides a method for purifying an HWE reagent that can selectively and effectively remove pyrophosphate esters contained in a trace amount in the HWE reagent without causing degradation or denaturation of the HWE reagent. It is intended.
本発明のHWE試薬の精製方法は、下記一般式(I)
で示されるHWE試薬中に含まれる下記一般式(II)
The following general formula (II) contained in the HWE reagent represented by
前記酸は鉱酸または固体酸であることが好ましい。
前記固体酸はケイ酸塩鉱物であることが好ましく、前記ケイ酸塩鉱物はスメクタイトであることが好ましい。
前記鉱酸は塩化水素、硫酸、リン酸、フッ化水素酸の水溶液であることが好ましい。
前記加水分解は加熱して行うことが好ましい。
The acid is preferably a mineral acid or a solid acid.
The solid acid is preferably a silicate mineral, and the silicate mineral is preferably smectite.
The mineral acid is preferably an aqueous solution of hydrogen chloride, sulfuric acid, phosphoric acid, or hydrofluoric acid.
The hydrolysis is preferably performed by heating.
前記一般式(I)としては、例えばR1がC2H5、XがCHCOOC2H5、YがCH3であって、前記一般式(II)としては、R2がC2H5のものが例示される。
また、前記一般式(I)においてR1がCH3、XがCHCOOC2H5、YがCH3であって、前記一般式(II)においてR2がCH3ものも例示できる。
As the general formula (I), for example, R 1 is C 2 H 5, X is CHCOOC 2 H 5 , Y is CH 3 , and R 2 is C 2 H 5 as the general formula (II). Are illustrated.
Further, there can be exemplified those in which R 1 is CH 3, X is CHCOOC 2 H 5 , Y is CH 3 in the general formula (I), and R 2 is CH 3 in the general formula (II).
本発明のHWE試薬の精製方法は、上記一般式(I)で示されるHWE試薬中に含まれる上記一般式(II)で示されるピロリン酸エステルを酸により加水分解するので、HWE試薬の分解や変性を起こすことなく、HWE試薬の中に極微量に含まれているHWE試薬と同種の官能基を有しているピロリン酸エステル類のみを選択的かつ効果的に除去することができる。 In the method for purifying the HWE reagent of the present invention, the pyrophosphate ester represented by the general formula (II) contained in the HWE reagent represented by the general formula (I) is hydrolyzed with an acid. Without causing denaturation, it is possible to selectively and effectively remove only pyrophosphate esters having the same type of functional group as the HWE reagent contained in a very small amount in the HWE reagent.
本発明のHWE試薬の精製方法は、下記一般式(I)
一般式(I)において、Xが炭素原子の場合の置換基としてはアルキル基、アリール基、シアノ基、イソシアノ基、アルコキシル基、アルコキシアルカン基、カルボキシル基、アルキルカルボニル基、アルコキシカルボニル基、等が挙げられる。
Yが炭素原子の場合の置換基も上記と同様である。
Yが酸素原子の場合の置換基としてはアルキル基、アリール基、カルボキシル基、アルコキシカルボニル基、等が挙げられる。
In the general formula (I), the substituent when X is a carbon atom includes an alkyl group, an aryl group, a cyano group, an isocyano group, an alkoxyl group, an alkoxyalkane group, a carboxyl group, an alkylcarbonyl group, an alkoxycarbonyl group, and the like. Can be mentioned.
The substituent when Y is a carbon atom is the same as above.
Examples of the substituent when Y is an oxygen atom include an alkyl group, an aryl group, a carboxyl group, and an alkoxycarbonyl group.
酸としては鉱酸や固体酸を用いることができる。鉱酸としては、例えば塩酸、硫酸、硝酸、リン酸等を好ましく挙げることができ、中でも、ピロリン酸エステル類をより選択的かつ効率的に除去できる点からすれば、塩酸または硫酸が好ましい。固体酸としてはケイ酸塩鉱物類や酸性イオン交換樹脂等を用いることができ、中でもゼオライトやスメクタイトが好ましく、さらには酸性白土や活性白土がより好ましい As the acid, a mineral acid or a solid acid can be used. As the mineral acid, for example, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid and the like can be preferably mentioned. Among them, hydrochloric acid or sulfuric acid is preferable from the viewpoint that pyrophosphates can be removed more selectively and efficiently. As the solid acid, silicate minerals and acidic ion exchange resins can be used, among which zeolite and smectite are preferable, and acidic clay and activated clay are more preferable.
ピロリン酸エステル類を除去する具体的な手順としては、ピロリン酸エステル類を0.005〜5質量%含有するHWE試薬1質量部に対して、酸として鉱酸を用いる場合にはその鉱酸の0.1〜10質量%、好ましくは1〜5質量%の水溶液を、0.5〜2質量部、好ましくは0.7〜1.2質量部加えて、1〜20時間攪拌する。その際の温度は30〜100℃に調整することが好ましく、HWE試薬の分解を抑えかつ効果的にピロリン酸エステル類を除去するためには、50〜80℃に加熱することが好ましい。 As a specific procedure for removing pyrophosphate esters, when a mineral acid is used as an acid with respect to 1 part by mass of HWE reagent containing 0.005 to 5 mass% of pyrophosphate esters, Add 0.5 to 2 parts by mass, preferably 0.7 to 1.2 parts by mass of an aqueous solution of 0.1 to 10% by mass, preferably 1 to 5% by mass, and stir for 1 to 20 hours. The temperature at that time is preferably adjusted to 30 to 100 ° C., and in order to suppress decomposition of the HWE reagent and effectively remove pyrophosphate esters, it is preferable to heat to 50 to 80 ° C.
このピロリン酸エステル類を除去できたかどうかは、ガスクロマトグラフィーにより確認することができる。加熱により充分ピロリン酸エステル類を除去した後、有機溶媒と塩化ナトリウムを添加し酸水溶液層を分液し、有機層のpHが3〜9、好ましくは4〜8になるまで塩化ナトリウムを添加したアルカリ水溶液で洗浄する。 Whether or not the pyrophosphates have been removed can be confirmed by gas chromatography. After sufficiently removing pyrophosphates by heating, an organic solvent and sodium chloride are added to separate the aqueous acid layer, and sodium chloride is added until the pH of the organic layer is 3 to 9, preferably 4 to 8. Wash with alkaline aqueous solution.
この際に用いる有機溶媒としてはHWE試薬を溶かすことができ、かつ水への溶解度がある程度小さく分液可能な有機溶媒であればいずれも使用可能であるが、例えば酢酸エチル、ジエチルエーテル、イソプロピルエーテル、ヘプタン、ペンタン、イソブタノール、キシレン等が好ましく挙げられる。
アルカリ水溶液で洗浄後、有機溶媒を濃縮することでピロリン酸エステル類が除去されたHWE試薬を得ることができる。
As the organic solvent used in this case, any organic solvent can be used as long as it can dissolve the HWE reagent and has a relatively low solubility in water and can be separated. For example, ethyl acetate, diethyl ether, isopropyl ether , Heptane, pentane, isobutanol, xylene and the like are preferable.
After washing with an aqueous alkali solution, the HWE reagent from which pyrophosphates have been removed can be obtained by concentrating the organic solvent.
また、酸として固体酸を用いる場合には上記の鉱酸に換えて、HWE試薬1質量部に対して0.001〜0.1質量部、好ましくは0.01〜0.05質量部の固体酸を加えて1〜20時間攪拌する。その際の温度は30〜100℃に調整することが好ましく、HWE試薬の分解を抑えかつ効果的にピロリン酸エステル類を除去するためには、50〜80℃に加熱することが好ましい。加熱により十分ピロリン酸エステル類を除去した後、ろ過により固体酸を取り除くことでピロリン酸エステル類を除去したHWE試薬を得ることができる。 Moreover, when using a solid acid as an acid, it replaces with said mineral acid, 0.001-0.1 mass part with respect to 1 mass part of HWE reagent, Preferably it is a solid of 0.01-0.05 mass part Add acid and stir for 1-20 hours. The temperature at that time is preferably adjusted to 30 to 100 ° C., and in order to suppress decomposition of the HWE reagent and effectively remove pyrophosphate esters, it is preferable to heat to 50 to 80 ° C. After removing pyrophosphates sufficiently by heating, the HWE reagent from which pyrophosphates have been removed can be obtained by removing the solid acid by filtration.
特にこの固体酸を用いた場合には鉱酸使用時と比較して、第一に後処理がろ過のみであり簡便である、第二に固体酸の回収再利用が可能である、第三に分液操作に伴う廃液の排出がないという利点を有しており、工業的に極めて有利な手段である。
以下、本発明のHWE試薬の精製方法について実施例を用いてさらに詳細に説明する。
In particular, when this solid acid is used, compared with the case of using a mineral acid, first, the post-treatment is only filtration and simple, and second, the solid acid can be recovered and reused. This has the advantage that there is no discharge of the waste liquid accompanying the liquid separation operation, and is an industrially extremely advantageous means.
Hereinafter, the purification method of the HWE reagent of the present invention will be described in more detail using examples.
<HWE試薬の合成>
公知の手法であるアルブゾフ反応を用いてHWE試薬(A)(一般式(1)において、R1がC2H5、XがCHCOOEt、YがCH3である)を合成した。
ガスクロマトグラフィーを用いた分析により、このHWE試薬中には0.0527GC面積%のピロリン酸テトラエチル(以下、TEPP)が含有されており、また同時にHWE試薬の純度は88.61GC面積%であることがわかった。さらにその外観は薄黄色であった。
<Synthesis of HWE reagent>
The HWE reagent (A) (in the general formula (1), R 1 is C 2 H 5, X is CHCOOEt, and Y is CH 3 ) was synthesized using a known technique of Arbuzov reaction.
According to analysis using gas chromatography, this HWE reagent contains 0.0527 GC area% tetraethyl pyrophosphate (hereinafter referred to as TEPP), and at the same time the purity of the HWE reagent is 88.61 GC area%. I understood. Furthermore, the appearance was light yellow.
(比較例1)
HWE試薬(A)(100g)に水(100g)を添加し、80℃で10時間加熱攪拌した。加熱終了後、分液し減圧濃縮により水分を取り除き、HWE試薬(98g)を得た。
(Comparative Example 1)
Water (100 g) was added to the HWE reagent (A) (100 g), and the mixture was heated and stirred at 80 ° C. for 10 hours. After completion of the heating, the solution was separated and water was removed by concentration under reduced pressure to obtain HWE reagent (98 g).
(比較例2)
HWE試薬(A)(100g)に0.1質量%水酸化ナトリウム水溶液(100g)を添加し、25℃で1時間攪拌した。攪拌終了後、イソプロピルエーテル(100g)と塩化ナトリウム(20g)を添加し、分液、水洗を行い、減圧濃縮により溶媒を留去することで、HWE試薬(90g)を得た。
(Comparative Example 2)
To the HWE reagent (A) (100 g) was added 0.1 mass% aqueous sodium hydroxide solution (100 g), and the mixture was stirred at 25 ° C. for 1 hour. After completion of the stirring, isopropyl ether (100 g) and sodium chloride (20 g) were added, followed by liquid separation and washing with water, and the solvent was distilled off under reduced pressure to obtain an HWE reagent (90 g).
(実施例1)
HWE試薬(A)(100g)に2質量%塩酸(100g)を添加し、55℃で10時間加熱攪拌した。加熱終了後、イソプロピルエーテル(100g)と塩化ナトリウム(20g)を添加して分液した後、1%炭酸ナトリウム水溶液(100g)に塩化ナトリウム(20g)を加えた水溶液で洗浄した。減圧濃縮により溶媒を留去することで、HWE試薬(95g)を得た。
Example 1
2% by mass hydrochloric acid (100 g) was added to the HWE reagent (A) (100 g), and the mixture was heated and stirred at 55 ° C. for 10 hours. After completion of the heating, isopropyl ether (100 g) and sodium chloride (20 g) were added for liquid separation, and the mixture was washed with an aqueous solution obtained by adding sodium chloride (20 g) to a 1% aqueous sodium carbonate solution (100 g). The solvent was removed by concentration under reduced pressure to obtain HWE reagent (95 g).
(実施例2)
HWE試薬(A)(100g)に酸性白土(関東化学株式会社製)(5g)を添加し、80℃で10時間加熱攪拌した。加熱終了後、No.5Bのろ紙を用いてろ過することでHWE試薬(95g)を得た。
(Example 2)
Acid white clay (manufactured by Kanto Chemical Co., Inc.) (5 g) was added to HWE reagent (A) (100 g), and the mixture was heated and stirred at 80 ° C. for 10 hours. After heating, No. HWE reagent (95 g) was obtained by filtering using 5B filter paper.
(実施例3)
HWE試薬(A)(100g)に活性白土(関東化学株式会社製)(5g)を添加し、80℃で10時間加熱攪拌した。加熱終了後、No.5Bのろ紙を用いてろ過することでHWE試薬(95g)を得た。
Example 3
Activated clay (manufactured by Kanto Chemical Co., Inc.) (5 g) was added to HWE reagent (A) (100 g), and the mixture was heated and stirred at 80 ° C. for 10 hours. After heating, No. HWE reagent (95 g) was obtained by filtering using 5B filter paper.
上記のようにして処理した比較例1、2および実施例1〜3のHWE試薬をガスクロマトグラフィーにより分析し、TEPPとHWE試薬のGC面積%及び外観が処理前後でどのように変化したかを表1にまとめた。なお、表1中のTEPP除去率およびHWE試薬保持率は、それぞれ以下の式により求めたものである。
TEPP除去率=処理後TEPPのGC面積%/処理前TEPPのGC面積%
HWE試薬保持率=処理後HWE試薬のGC面積%/処理前HWE試薬のGC面積%
The HWE reagents of Comparative Examples 1 and 2 and Examples 1 to 3 treated as described above were analyzed by gas chromatography, and how the GC area% and appearance of TEPP and HWE reagents changed before and after the treatment. The results are summarized in Table 1. In addition, the TEPP removal rate and the HWE reagent retention rate in Table 1 are obtained by the following equations, respectively.
TEPP removal rate = GC area% of TEPP after treatment / GC area% of TEPP before treatment
HWE reagent retention rate = GC area% of HWE reagent after treatment / GC area% of HWE reagent before treatment
表1に示すように、水のみを使用してTEPPの除去を行った比較例1では、処理によるTEPP除去率が42.4%であり、十分に除去されたとは言えなかった。水酸化ナトリウムを用いた比較例2では、TEPP除去率は95%以上と十分であったが、HWE試薬保持率が98.4%となり、HWE試薬の分解が認められた。また、外観も処理前は薄黄色であったものが濃黄色となっており変性が認められた。 As shown in Table 1, in Comparative Example 1 in which TEPP was removed using only water, the TEPP removal rate by the treatment was 42.4%, and it could not be said that it was sufficiently removed. In Comparative Example 2 using sodium hydroxide, the TEPP removal rate was sufficient to be 95% or more, but the HWE reagent retention rate was 98.4%, and decomposition of the HWE reagent was observed. In addition, the appearance was light yellow before the treatment, but became dark yellow, and the modification was recognized.
一方で、本発明のHWE試薬の精製方法による実施例1〜3ではTEPPの除去率が95%以上と十分な値を示しており、またHWE試薬保持率の低下や外観の変性も認められなかった。 On the other hand, in Examples 1 to 3 according to the purification method of the HWE reagent of the present invention, the removal rate of TEPP is 95% or more, which is a sufficient value, and the decrease in the retention rate of HWE reagent and the appearance are not observed. It was.
以上の実施例から明らかなように、本発明のHWE試薬の精製方法は、HWE試薬中に含まれるピロリン酸エステルを、酸により加水分解することで、HWE試薬を分解させたり変性させたりすることなく、HWE試薬の中に極微量に含まれているピロリン酸エステル類のみを選択的かつ効果的に除去することができる。 As is clear from the above examples, the method for purifying the HWE reagent of the present invention involves decomposing or modifying the HWE reagent by hydrolyzing the pyrophosphate ester contained in the HWE reagent with an acid. In addition, only pyrophosphate esters contained in a very small amount in the HWE reagent can be selectively and effectively removed.
Claims (8)
で示されるホーナー・ワズワース・エモンズ試薬中に含まれる下記一般式(II)
で示されるピロリン酸エステルを、酸により加水分解することを特徴とするホーナー・ワズワース・エモンズ試薬の精製方法。 The following general formula (I)
The following general formula (II) contained in the Horner-Wadsworth-Emmons reagent represented by
A method for purifying a Horner-Wadsworth-Emmons reagent, which comprises hydrolyzing a pyrophosphate ester represented by the formula:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011071941A JP5650031B2 (en) | 2011-03-29 | 2011-03-29 | Purification method for Horner-Wadsworth-Emmons reagent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011071941A JP5650031B2 (en) | 2011-03-29 | 2011-03-29 | Purification method for Horner-Wadsworth-Emmons reagent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012206950A JP2012206950A (en) | 2012-10-25 |
| JP5650031B2 true JP5650031B2 (en) | 2015-01-07 |
Family
ID=47187025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011071941A Expired - Fee Related JP5650031B2 (en) | 2011-03-29 | 2011-03-29 | Purification method for Horner-Wadsworth-Emmons reagent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5650031B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101933731B1 (en) | 2011-04-27 | 2018-12-28 | 코와 가부시키가이샤 | Method for manufacturing phosphonocrotonic acid derivative |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5001250A (en) * | 1989-05-30 | 1991-03-19 | Occidental Chemical Corporation | Purification of bidentate organophosphorous extractants |
| JP4508394B2 (en) * | 2000-09-20 | 2010-07-21 | 三菱瓦斯化学株式会社 | Purification method of organic phosphonic acid |
-
2011
- 2011-03-29 JP JP2011071941A patent/JP5650031B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012206950A (en) | 2012-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102268037B (en) | Process for purifying glufosinate-ammonium | |
| CN101531681B (en) | High-purity minodronic acid and preparation method thereof | |
| CN113880903B (en) | Preparation method of monabivalir | |
| KR20110127152A (en) | Method for preparing free acid from its salt | |
| MX2014006249A (en) | Method for producing and purifying salts of acrylamido-2-methylpr opane sulfonic acid. | |
| RU2011141429A (en) | IMPROVED METHOD FOR PRODUCING MEROPENEM USING ZINC POWDER | |
| CN102180823A (en) | Method for refining prolinamide | |
| CN101845017A (en) | Preparation method of atracurium besilate intermediates | |
| JP5650031B2 (en) | Purification method for Horner-Wadsworth-Emmons reagent | |
| CN104016961B (en) | A kind of preparation method of rosuvastain calcium intermediate | |
| CN112321475A (en) | Gamma-amino acid analogue and synthetic method thereof | |
| EP2383252B1 (en) | Method for manufacturing hydroxyl group substitution product | |
| JPH03181493A (en) | Preparation of pure cyclic diarylester phophate | |
| CN110863020B (en) | Method for synthesizing metamifop by enzyme method | |
| CN109384814B (en) | Purification method of novel tenofovir prodrug | |
| JP5166747B2 (en) | Method for purifying alkylaminopyridines | |
| CN106632340B (en) | A method of synthesis tenofovir intermediate | |
| DE602006008335D1 (en) | NOVEL METHOD FOR THE PRODUCTION OF QUATERNIC ACID AND AMMONIUM SALTS | |
| JP2002114737A (en) | METHOD FOR PRODUCING OPTICALLY ACTIVE o-CHLOROMANDELIC ACID | |
| JP2013540761A (en) | Improved synthesis of peretinoin | |
| JP2004269369A (en) | Purification method of sucrose fatty acid ester | |
| CN114075244B (en) | Bidentate phosphite ester and purification method and application thereof | |
| EP1970369B1 (en) | Method for producing purified formylcyclopropane compound and intermediate of such formylcyclopropane compound | |
| Smolin | Development of Late-Stage Functionalization of Chiral Bisphosphorylimides | |
| RU2432351C1 (en) | Method of producing 4-nitrostyrene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20131001 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20131001 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20131001 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20131001 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20131225 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20141022 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141104 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141112 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5650031 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |